BLINCYTO
Drug timelines are a Plus or Pro feature.
51 regulatory and trial events tracked for BLINCYTO, covering 2014-12-03 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia [Phase 1, Phase 2]